<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        25-399-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CEFODOX 100MG-5ML SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFPODOXIME
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        53
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 513]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI ARABIAN DRUG STORE COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DD13
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cefodox &reg; Oral Suspension 100mg/5ml contains a medicine called cefpodoxime. This<br />belongs to a group of antibiotics called &lsquo;cephalosporins&rsquo;.<br />Cefodox &reg; Oral Suspension and 100mg/5ml is specially made for children.<br />The bottle contains powder which has been mixed with water by your pharmacist.<br />The suspension is lemon flavored powder and is ready to use.<br />Cefodox &reg; Oral Suspension is used to treat infections caused by bacteria. These include<br />infections of the:<br />&bull; ear<br />&bull; nose, sinuses (such as sinusitis)<br />&bull; throat (such as tonsillitis, pharyngitis)<br />&bull; chest and lungs (such as bronchitis, pneumonia)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not give this medicine to your child if:<br />-Your child is allergic (hypersensitive) to cefpodoxime, any other tibiotics<br />including penicillin or to any of the other ingredients of this medicine (listed in section<br />6 :further information).<br />Signs of an allergic reaction include: a rash, swallowing or breathing problems,<br />swelling of the lips, face, throat and tongue.<br />Do not give this medicine to your children if any of the above applies to them. If you<br />are not sure, talk to your child&rsquo;s doctor or your pharmacist before giving Cefodox &reg;<br />Oral Suspension.<br />Take special care with Cefodox &reg; Oral Suspension<br />Check with your child&rsquo;s doctor or your pharmacist before giving this medicine if your<br />child:<br />&bull; Has ever had colitis<br />&bull; Has kidney problems<br />&bull; Is under 15 days old<br />&bull; Your child cannot tolerate or digest some sugars (as this product contains Sodium<br />Sucrose )<br />&bull; this product contains Sodium Saccharine<br />&bull; If you have ever had inflammation of your bowel, called colitis or any other severe<br />disease affecting your gut.<br />&bull; This medicine can alter the results of some blood tests (such as cross-matching blood<br />and the coomb&rsquo;s test). It is important to tell the doctor that you are taking this medicine<br />if you have to have any of these tests.<br />&bull; This medicine can also alter the results of urine tests for sugar (such as Benedict&rsquo;s<br />or Fehling&rsquo;s tests). If you have diabetes and routinely test your urine, tell your doctor.<br />This is because other tests may have to be used to monitor your diabetes while you are<br />having this medicine.<br />If you are not sure if any of the above apply to your child, talk to your doctor or<br />pharmacist before giving this medicine.<br />Taking other medicines<br />Please tell your child&rsquo;s doctor or your pharmacist if your child is taking or has recently<br />taken any other medicines. This includes medicines you buy without a prescription,<br />including herbal medicines. This is because Cefodox &reg; Oral Suspension can affect the<br />way some other medicines work. Also some medicines can affect the way Cefodox &reg;<br />Oral Suspension works.<br />In particular, tell your child&rsquo;s doctor if they are taking any of the following:<br />&bull; antacids (used to treat indigestion)<br />&bull; medicines for treating ulcers (such as ranitidine or cimetidine)<br />&bull; water tablets or injections (diuretics) used to increase the flow of your water (urine)<br />&bull; aminoglycoside antibiotics (used to treat infections)<br />&bull; Probenecid (used in the treatment of gout).<br />&bull; coumarin anti-coagulants such as warfarin (used to thin the blood)<br />Take antacids and medicines for ulcers 2-3 hours after Cefodox &reg; Oral Suspension. Your<br />child&rsquo;s doctor knows about this and will change the treatment if needed.<br />Tests<br />If your child requires any tests (such as blood or urine tests) while taking this<br />medicine, please make sure your child&rsquo;s doctor knows that your child is taking<br />Cefodox &reg; Oral Suspension.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Cefpodoxime exactly as your doctor has told you. You should check with<br />your doctor or pharmacist, if you are not sure.<br />Instructions for Reconstitution:<br />Invert the bottle and shake powder loose. Add boiled and cooled water in two portions<br />up to the mark indicated on the bottle; shake after each addition until a homogeneous<br />suspension is achieved.<br />Cefodox &reg; for oral suspension may be given without regard to food. The recommended<br />dosages, durations of treatment, and applicable patient populations are as described in<br />the following chart:<br />Adults and Adolescents (age 12 years and older):</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="text-align:center; width:176px">Type of Infection</td><td style="text-align:center; width:107px">Total<br />Daily<br />Dose</td><td style="text-align:center">Dose Frequency</td><td style="text-align:center">Duration</td></tr><tr><td style="text-align:center; width:176px">Pharyngitis and/or<br />tonsillitis</td><td style="text-align:center; width:107px">200 mg<br />(10 ml )</td><td style="text-align:center">100 mg (5 ml) Q<br />12 hours</td><td style="text-align:center">5 to 10<br />days</td></tr><tr><td style="text-align:center; width:176px">Acute communityacquired<br />pneumonia</td><td style="text-align:center; width:107px">400 mg<br />(20 ml )</td><td style="text-align:center">200 mg (10 ml) Q<br />12 hours</td><td style="text-align:center">14 days</td></tr><tr><td style="text-align:center; width:176px">Acute maxillary<br />sinusitis</td><td style="text-align:center; width:107px">400 mg<br />(20 ml )</td><td style="text-align:center">200 mg (10 ml) Q<br />12 hours</td><td style="text-align:center">10 days</td></tr></tbody></table><p>Infants and Pediatric Patients (age 2 months through 12 years):</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="text-align:center">Type of Infection</td><td style="text-align:center">Total Daily Dose</td><td style="text-align:center">Dose Frequency</td><td style="text-align:center">Duration</td></tr><tr><td style="text-align:center">Acute otitis media</td><td style="text-align:center">10 mg/kg/day<br />0.5 ml/kg/day<br />(Max 400 mg/day<br />equ. 20ml/day)</td><td style="text-align:center">5 mg/kg Q 12 h<br />(0.25 ml/kg Q<br />12 h)<br />(Max 200 mg/dose<br />equ. 10ml/dose)</td><td style="text-align:center">5 days</td></tr><tr><td style="text-align:center">Pharyngitis and/or<br />tonsillitis</td><td style="text-align:center">10 mg/kg/day<br />0.5 ml/kg/day<br />(Max 200 mg/day<br />equ. 10ml/day)</td><td style="text-align:center">5 mg/kg/dose<br />Q 12 h<br />(0.25 ml/kg Q<br />12 h)<br />(Max 100 mg/dose<br />equ. 5 ml/dose)</td><td style="text-align:center">5 to 10 days</td></tr><tr><td style="text-align:center">Acute maxillary<br />sinusitis</td><td style="text-align:center">10 mg/kg/day<br />0.5 ml/kg/day<br />(Max 400 mg/day<br />equ. 20ml/day)</td><td style="text-align:center">5 mg/kg Q 12 h<br />(0.25 ml/kg Q<br />12 h)<br />(Max 200 mg/dose<br />equ. 10ml/dose)</td><td style="text-align:center">10 days</td></tr></tbody></table><p>Patients with Renal Dysfunction:<br />For patients with severe renal impairment (&lt;30 mL/min creatinine clearance),<br />the dosing intervals should be increased to Q 24 hours. In patients maintained on<br />hemodialysis, the dose frequency should be 3 times/week after hemodialysis.<br />When only the serum creatinine level is available, the following formula (based on<br />sex, weight, and age of the patient) may be used to estimate creatinine clearance (mL/</p><p>min). For this estimate to be valid, the serum creatinine level should represent a steady<br />state of renal function.<br />Males (mL/min): Weight (kg) x (140 - age) / (72 x serum creatinine (mg/100 mL))<br /><br />Females (mL/min): 0.85 x above value</p><p>Patients with Cirrhosis:<br />Cefpodoxime pharmacokinetics in cirrhotic patients (with or without ascites) are similar<br />to those in healthy subjects. Dose adjustment is not necessary in this population.<br />If you take more Cefodox&reg; Oral Suspension than you should<br />If you accidentally take too much medicine, contact your doctor or pharmacist who will<br />recommend what action you should take.<br />If you forget to take Cefodox&reg; Oral Suspension<br />If you do forget to take a dose of your medicine at the correct time, you should take it as<br />soon as possible. However, if it is almost time for your next dose, skip the missed dose.<br />Do not take a double dose to make up for a forgotten dose. Just take the next dose at the<br />correct time. Carry on as before.<br />If you stop taking Cefodox&reg; Oral Suspension<br />Keep taking your medicine until your doctor has told you to stop. Do not stop taking it<br />just because you feel better. If you stop taking the medicine, your condition may reoccur<br />or get worse.<br />If you have any further questions on the use of this product, ask your doctor or<br />pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Cefodox&reg; can cause side effects, although not everybody gets them.<br />The side effects are listed by frequency.<br />Conditions you need to look out for<br />The following serious side effects have occurred in a small number of people but their<br />exact frequency is unknown:<br />&bull; Severe allergic reaction. Signs include raised and itchy rash, swelling, sometimes of the<br />face or mouth causing difficulty in breathing.<br />&bull; Skin rash, which may blister, and looks like small targets (central dark spot surrounded<br />by a paler area, with a dark ring around the edge).<br />&bull; A widespread rash with blisters and peeling skin. (These may be signs of Stevens<br />Johnson syndrome or toxic epidermal necrolysis).<br />All of these reactions need urgent medical attention. If you think you are having any<br />of these types of reaction, stop taking this medicine and contact your doctor or your<br />nearest hospital accident and emergency department.<br />Common side effects (affects more than 1 person in 100 but less than 1 in 10):<br />&bull; Stomach problems: Bloating, nausea, vomiting, stomach pain, flatulence (wind) and<br />diarrhea.<br />&bull; Loss of appetite.<br />If you have severe diarrhea or if you see blood in your diarrhea you should stop taking<br />this medicine and talk to your doctor immediately.<br />Uncommon side effects &middot; (affects more than 1 person in 1,000 but less than 1 in 100):<br />&bull; Hypersensitivity reactions (These are skin rashes that are less severe allergic reactions<br />than mentioned above, lumpy rash (hives), itching).<br />&bull; Headache.<br />&bull; Pins and needles.<br />&bull; Dizziness.<br />&bull; Ringing in the ears.<br />&bull; Weakness and a feeling of generally being unwell.<br />Rare side effects (affects more than 1 person in 10,000 but less than 1 in 1,000):<br />&bull; Changes in blood tests that check how your liver is working.<br />&bull; Anaemia<br />&bull; Drops in the numbers of blood cells (symptoms can include tiredness, new infections<br />and easy bruising or bleeding).<br />&bull; Increase in some types of white blood cells.<br />&bull; Increase in the numbers of small cells that are needed for clotting of the blood.<br />Very rare side effects (affects less than 1 person in 10,000):<br />&bull; Anaphylactic reactions (e.g. bronchospasms, purpura and edema of the face and<br />extremities)<br />&bull; Worsening in the kidney function<br />&bull; Liver damage<br />&bull; Having a course of cefpodoxime can temporarily increase the chance that you can get<br />infections caused by other sorts of germs. For example, thrush may occur.<br />&bull; A type of anaemia that can be severe and is caused by red blood cells breaking up.<br />If any of the side effects gets serious, or if you notice any side effects not listed in this<br />leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not use Cefodox &reg; Oral Suspension after the expiry date (EXP) which is stated on<br />the carton.<br />The expiry date refers to the last day of the month.<br />Cefodox &reg; Oral Suspension: Store dry powder below 30oC.<br />The reconstituted suspension should be used within 14 days, and to be stored in the<br />refrigerator (2-8&deg;C).<br />Any liquid remaining after 14 days should be disposed of properly.<br />Medicines should not be disposed of via wastewater or household waste.<br />Ask your pharmacist how to dispose of medicines no longer required. These measures<br />will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Each 5ml spoonful of liquid contains 100mg of the active substance<br />cefpodoxime proxetil<br />&bull; The other ingredients are Hydroxy propyl cellulose, Microcrystalline cellulose, Maize<br />starch, Sucrose, Citric acid, Colloidal silicon dioxide, Simethicone emulsion , Microcrystalline<br />cellulose and Carboxymethyl cellulose, Sodium saccharin, Xanthan gum, Lemon<br />powder flavor, Vanilla powder flavor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cefodox ® Oral Suspension and 100mg/5ml are available in 100ml bottles and come with
a measuring spoon (10ml) & a Child resistant cap.
The bottle contains powder which has been mixed with water by your pharmacist, to form
a Lemon flavoured medicine ready for use.
(Not all pack sizes may be marketed in your country)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharma International Company<br />Amman - Jordan<br />Tel: 00962-6-5158890 / 5157893<br />Fax: 00962-6-5154753<br />Email: marketing@pic-jo.com</p><p>This leaflet does not contain all the information about your medicine. If you have any<br />questions or are not sure about anything, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 12/2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>سيفودوكس&reg; معلق للشرب 100 ملغم / 5مل يحتوي على دواء يدعى سيفبودوكسيم بروكسيتيل. هذا ينتمي إلى<br />مجموعة من المضادات الحيوية يدعى السيفالوسبورينات.</p><p>&nbsp;</p><p>سيفودوكس&reg;&nbsp;معلق للشرب 100 ملغم / 5مل صنع خصيصا للأطفال.</p><p>تحتوي الزجاجة على مسحوق قام الصيدلي بخلطه مع المياه المعقمة.<br />هذا مسحوق بنكهة الليمون وجاهزة للاستخدام.<br />يستخدم سيفودوكس &reg; معلق للشرب لعلاج الالتهابات التي تسببها البكتيريا. وتشمل هذه الإلتهابات:<br />&bull; الأذن<br />&bull; الأنف، الجيوب الأنفية (مثل التهاب الجيوب الأنفية)<br />&bull; الحلق (مثل التهاب اللوزتين، التهاب البلعوم)<br />&bull; الصدر والرئتين (مثل الالتهاب الرئوي والتهاب الشعب الهوائية)</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تعطي هذا الدواء لطفلك إذا:<br />- يعاني طفلك من حساسية (فرط الحساسية) للسيفيودوكسيم،أو أي من مضادات حيوية الأخرى بما في ذلك<br />البنسلين, أو أي من المكونات الأخرى لهذا الدواء.<br />بما في ذلك البنسلين, أو الى أي من المكونات الأخرى لهذا الدواء. (المذكورة في البند 6: لمزيد من المعلومات).<br />وتشمل علامات الحساسية: طفح جلدي، مشاكل في البلع أو التنفس،تورم في الشفتين والحلق والوجه واللسان.<br />لا تعطي هذا الدواء لأطفالك إذا كان أي من أعلاه ينطبق عليهم. إذا كنت غير متأكد، تحدث مع طبيب طفلك او<br />الصيدلي الخاص بك قبل إعطاء سيفودوكس&reg;&nbsp;معلق للشرب.<br />تعامل مع سيفودوكس&reg; معلق للشرب&nbsp;بنوع من الحذر<br />تحقق مع طبيب طفلك او الصيدلي الخاص بك قبل إعطاء هذا الدواء إذا كان طفلك:<br />&bull; قد عانى في أي وقت مضى من التهاب القولون<br />&bull; لديه مشاكل في الكلى<br />&bull; يقل عمره عن 15 يوما<br />&bull; لا يمكن له أن يتحمل أو أن يهضم بعض أنواع السكريات (هذا المنتج يحتوي على السكروز)<br />&bull; هذا المنتج يحتوي على سكرين الصوديوم<br />&bull; إذا عانيت من التهاب في الأمعاء، يعرف بالتهاب القولون أو أي مرض حاد آخر يؤثر على الأمعاء.<br />&bull; قد يغير هذا الدواء من نتائج بعض فحوصات الدم (مثل فحص مطابقة الدم وفحص كومب). من الضروري إخبار<br />الطبيب بأنك تتناول هذا الدواء إذا كنت ستخضع لأي من هذه الفحوصات.<br />&bull; قد يغير هذا الدواء أيضا من نتائج فحوصات البول المتعلقة بمستوى السكر (مثل فحص بينيديكت أو فهلينج). إذا<br />كنت تعاني من داء السكري وتخضع لفحص البول بشكل دوري، أخبر طبيبك. هذا لأنه قد يكون من الضروري<br />الخضوع لفحوصات أخرى لمراقبة داء السكري خلال فترة تناول هذا الدواء.<br />&bull; إذا لم تكن متأكدا مما إذا كان أي من أعلاه تنطبق على طفلك، تحدث مع طبيبك أوالصيدلي قبل إعطاء هذا<br />الدواء.<br />تناول أدوية أخرى<br />يرجى إخبار الطبيب طفلك أو الصيدلي إذا كان طفلك يأخذ (أو أخذ) مؤخرا أية أدوية أخرى. وهذا يشمل الأدوية<br />التي تشتري دون وصفة طبية، بما في ذلك الأدوية العشبية. وذلك لأن سيفودوكس&reg;&nbsp;معلق للشرب يمكن أن<br />يؤثر على طريقة عمل بعض الأدوية الأخرى. كما يمكن لبعض الأدوية أن تؤثر على طريقة عمل سيفودوكس&reg;<br />معلق للشرب.<br />على وجه الخصوص، أخبر طبيب طفلك إذا كان يأخذ أي مما يلي:<br />&bull; مضادات الحموضة (التي تستخدم لعلاج عسر الهضم)<br />&bull; الأدوية لعلاج قرحة المعدة (مثل رانيتيدين أو السيميتيدين)<br />&bull; أقراص أو حقن المياه (مدرات البول) تستخدم لزيادة تدفق المياه (البول)<br />&bull; المضادات الحيوية أمينوغليكوسايد &bull; (تستخدم لعلاج الالتهابات)<br />&bull; بروبينيسيد (يستعمل لعلاج النقرس).<br />&bull; مضادات التخثر الكومارين مثل الوارفارين (التي تستخدم لتمييع الدم)<br />خذ مضادات الحموضة وأدوية القرحة 2-3 ساعات بعد أخذ سيفودوكس&reg; معلق للشرب. طبيب طفلك يعرف<br />عن هذا وسوف يغيير العلاج إذا لزم الأمر.<br />الفحوصات المخبرية<br />إذا كان طفلك يحتاج أي فحوصات مخبرية (مثل إختبارات الدم أو اختبارات البول) أثناء تناول هذا الدواء يرجى<br />التأكد من أن طبيب طفلك يعرف أنه يأخذ سيفودوكس&reg;&nbsp;معلق للشرب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول هذا الدواء تماما كما أخبرك طبيبك. يجب التأكد من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p>تعليمات التحضير</p><p dir="RTL">اقلب الزجاجة ورجها لينزل المسحوق عن جدران الزجاجة، قم بإضافة الماء المغلي والمبرد على دفعتين إلى</p><p dir="RTL">العالمة المبينة على الزجاجة، ثم رج جيدا بعد كل إضافة للحصول على معلق للشرب متجانس.</p><p dir="RTL">من الممكن تناول<strong> </strong><strong>سيفودوكس</strong><strong>&reg;</strong>&nbsp;معلق للشرب مع أو بدون تناول الطعام.</p><p dir="RTL">الجرعة الموصى بها، مدة العلاج، و المرضى الذين من الممكن أن يتناولوا هذا الدواء موصوفة في الجدول التالي:</p><p>البالغون والمراهقون (الذين تبلغ أعمارهم 12 عاما وأكبر)</p><table border="1" cellspacing="1" cellpadding="1" style="width:587px"><tbody><tr><td style="text-align:center">نوع الالتهاب</td><td style="text-align:center">الجرعة اليومية<br />الكلية</td><td style="text-align:center">تكرار الجرعة</td><td style="text-align:center; width:94px">مدة العلاج</td></tr><tr><td style="text-align:center">التهاب البلعوم و/أو<br />التهاب اللوزتين</td><td><p style="text-align:center">200 ملغم</p><p style="text-align:center">(10 مل)</p></td><td><p style="text-align:center">100 ملغم (5 مل) كل</p><p style="text-align:center">12 ساعة</p></td><td style="text-align:center; width:94px">5 إلى 10 أيام</td></tr><tr><td style="text-align:center">التهاب الرئة المكتسب<br />من المجتمع</td><td><p style="text-align:center">400 ملغم</p><p style="text-align:center">(20 مل)</p></td><td><p style="text-align:center">200 ملغم (10 مل) كل</p><p style="text-align:center">12 ساعة</p></td><td style="text-align:center; width:94px">14 يوم</td></tr><tr><td style="text-align:center">التهاب الجيوب<br />الفكية الحاد</td><td><p style="text-align:center">400 ملغم</p><p style="text-align:center">(20 مل)</p></td><td><p style="text-align:center">200 ملغم (10 مل)&nbsp;كل</p><p style="text-align:center">12 ساعة</p></td><td style="text-align:center; width:94px">10 أيام</td></tr></tbody></table><p>الرضع والأطفال (الذين تبلغ أعمارهم شهرين إلى 12 عاما)</p><table border="1" cellspacing="1" cellpadding="1" style="width:583px"><tbody><tr><td style="text-align:center">نوع الالتهاب</td><td style="text-align:center; width:197px">الجرعة اليومية الكلية</td><td style="text-align:center; width:193px">تكرار الجرعة</td><td style="text-align:center; width:90px">مدة العلاج</td></tr><tr><td style="text-align:center">التهاب الأذن<br />الوسطى الحاد</td><td style="text-align:center; width:197px">10 ملغم/كغم/يوم<br />(0.5 مل/ كغم/يوم)<br />(تبلغ الجرعة القصوى 400<br />ملغم/يوم ما يعادل 20 مل/يوم)</td><td style="text-align:center; width:193px">5 ملغم/كغم كل 12 ساعة<br />(0.25 مل/ كغم كل&nbsp;<br />12 ساعة)<br />(بحد أقصى 200 ملغم/<br />جرعة ما يعادل 10 مل/<br />جرعة)</td><td style="text-align:center; width:90px">5 أيام</td></tr><tr><td style="text-align:center">التهاب البلعوم<br />و/أو التهاب<br />اللوزتين</td><td style="text-align:center; width:197px">10 ملغم/كغم/يوم<br />(0.5 مل/ كغم/يوم)<br />(تبلغ الجرعة القصوى 200<br />ملغم/يوم ما يعادل 10 مل/يوم)</td><td style="text-align:center; width:193px">5 ملغم/كغم كل 12 ساعة<br />(0.25 مل/ كغم كل&nbsp;<br />12 ساعة)<br />(بحد أقصى 100 ملغم/<br />جرعة ما يعادل 5 مل/<br />جرعة)</td><td style="width:90px"><p style="text-align:center">5 إلى</p><p style="text-align:center">10 أيام</p></td></tr><tr><td style="text-align:center">التهاب الجيوب<br />الفكية الحاد</td><td style="text-align:center; width:197px">10 ملغم/كغم/يوم<br />(0.5 مل/ كغم/يوم)<br />(تبلغ الجرعة القصوى 400<br />ملغم/يوم ما يعادل 20 مل/يوم)</td><td style="text-align:center; width:193px">5 ملغم/كغم كل 12 ساعة<br />(0.25 مل/ كغم كل&nbsp;<br />12 ساعة)<br />(بحد أقصى 200 ملغم/<br />جرعة ما يعادل 10 مل/<br />جرعة)</td><td style="text-align:center; width:90px">10 أيام</td></tr></tbody></table><p>المرضى الذين يعانون من قصور في وظيفة الكلى:<br />للمرضى الذين يعانون من قصور حاد في وظيفة الكلى (تصفية الكرياتينين &lt;30 مل/دقيقة)، يجب زيادة المدة بين<br />الجرعات لتكون كل 24 ساعة. عند المرضى الذين يخضعون للديلزة الدموية، يجب أن يكون تكرار الجرعة 3<br />مرات/أسبوع بعد الخضوع للديلزة الدموية.<br />عند توفر مستوى الكرياتينين في المصل فقط، من الممكن استعمال الصيغة التالية (بالاعتماد على جنس، وزن،</p><p>وعمر المريض( لتقدير تصفية الكرياتينين. ولكي يكون هذا التقدير صحيحا، ينبغي أن يمثل مستوى الكرياتينين في<br />الدم حالة مستقرة من وظائف الكلى.</p><p>الذكور&nbsp;(مل/دقيقة): الوزن (كغم) * (140 - العمر) / (72 * كرياتينين المصل (ملفم/100مل)<br />الإناث (مل/دقيقة): 0.85 *&nbsp;القيمة الناتجة من الأعلى</p><p><strong>&nbsp;</strong></p><p dir="RTL">المرضى الذين يعانون من التليف الكبدي:</p><p dir="RTL">إن الحركية الدوائية لسيفبودوكسيم عند المرضى الذين يعانون من التليف الكبدي (مع أو بدون تجمع السوائل داخل</p><p dir="RTL">التجويف البطني)&nbsp;مشابهة لتلك عند األشخاص الأصحاء. لا&nbsp;يوجد حاجة لتعديل الجرعة عند هؤلاء&nbsp;الأشخاص.</p><p>إذا قمت بتناول سيفودوكس&reg;&nbsp;معلق للشرب أكثر مما يجب</p><p dir="RTL">إذا تناولت أكثر مما يجب من الدواء عن طريق الخطأ، اتصل مع طبيبك أو الصيدلي الذي سيوصيك باتخاذ</p><p dir="RTL">الإجراء المناسب.</p><p dir="RTL">إذا نسيت تناول جرعة سيفودوكس&reg;&nbsp;معلق للشرب</p><p dir="RTL">إذا نسيت تناول جرعة من دوائك في الوقت المناسب، يجب تناولها في أقرب وقت ممكن. لكن، إذا اقترب موعد</p><p dir="RTL">الجرعة التالية، اترك الجرعة التي نسيتها. لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها. فقط تناول</p><p dir="RTL">الجرعة التالية في الوقت المناسب. واستمر كما في السابق.</p><p>إذا توقفت عن تناول سيفودوكس&reg;&nbsp;معلق للشرب</p><p dir="RTL">استمر في تناول دوائك إلى أن يخبرك طبيبك بالتوقف عن ذلك. ال تتوقف عن تناوله فقط لأنك تشعر بتحسن. إذا</p><p dir="RTL">توقفت عن تناول الدواء، قد يعود الالتهاب&nbsp;مرة أخرى أو قد يزداد سوءا.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استعمال هذا الدواء، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع األدوية، قد يسبب<strong> </strong>سيفودوكس&reg;&nbsp;آثارا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">تم تصنيف اآلثار الجانبية حسب التكرار.</p><p>حاالت يجب االنتباه لحدوثها</p><p dir="RTL">إن الآثار الجانبية الخطيرة التالية حصلت عند عدد قليل من الأشخاص لكن تكرار حدوثها الدقيق غير معروف:<br />&bull;&thinsp;تفاعل تحسسي حاد. تشمل العلامات طفح بارز على سطح الجلد ويسبب الحكة، تورم، أحيانا في الوجه أو الفم<br />مما يسبب صعوبة في التنفس.<br />&bull;&thinsp;طفح جلدي، الذي قد يسبب تنفط، ويظهر كبقع صغيرة (بقع ذات مركز داكن محاط بمنطقة أكثر شحوبا، محاطة<br />بحلقة داكنة على الأطراف).<br />&bull;&thinsp;طفح واسع الانتشار مصحوبا بتنفط و تقشر الجلد. (قد تكون هذه علامات متلازمة ستيفن جونسون أو تحلل<br />نخري سام في البشرة).<br />تحتاج جميع هذه التفاعلات عناية طبية طارئة. إذا كنت تعتقد بأنك تعاني من أحد أنواع هذه التفاعلات، توقف<br />عن تناول هذا الدواء واتصل مع طبيبك أو قسم الطوارئ والحوادث في أقرب مستشفى.</p><p dir="RTL">آثار جانبية شائعة (تؤثر على أكثر من 1 من كل 100 شخص لكن أقل من 1 من كل 10 أشخاص):<br />&bull;&thinsp;مشاكل في المعدة: انتفاخ البطن، الشعور بالغثيان، قيء، ألم في المعدة، نفخة (ريح)&nbsp;وإسهال.<br />&bull;&thinsp;فقدان الشهية.<br />إذا كنت تعاني من إسهال حاد أو إذا لاحظت وجود الدم في الإسهال يجب التوقف عن تناول هذا الدواء و التحدث<br />مع طبيبك فورا.<br />آثار جانبية غير شائعة (تؤثر على أكثر من 1 من كل 1000 شخص لكن أقل من 1 من كل 100 شخص):<br />&bull;&thinsp;تفاعلات فرط التحسس (تشمل طفح الجلد الذي يكون أقل حدة من تفاعلات التحسس المذكورة في الأعلى، طفح<br />كتلي (شرى)، حكة).<br />&bull;&thinsp;صداع.<br />&bull;&thinsp;تشوش الحس.<br />&bull;&thinsp;الشعور بالدوار.<br />&bull;&thinsp;رنين في الأذنين.<br />&bull;&thinsp;الشعور بالضعف و الشعور العام بالمرض.<br />آثار جانبية نادرة (تؤثر على أكثر من 1 من كل 10000 شخص لكن أقل من 1 من كل 1000 شخص):<br />&bull;&thinsp;تغيرات في نتائج فحوصات الدم المتعلقة بصحة وظيفة الكبد.<br />&bull;&thinsp;فقر الدم.<br />&bull;&thinsp;انخفاض في عدد خلايا الدم (قد تتضمن الأعراض الشعور بالتعب، الإصابة بالتهابات جديدة، التعرض للكدمات<br />أوالنزيف بسهولة).<br />&bull;&thinsp;زيادة عدد بعض أنواع خلايا الدم البيضاء.<br />&bull;&thinsp;زيادة عدد خلايا صغيرة ضرورية لتجلط الدم.<br />آثار جانبية نادرة جدا (تؤثر على أقل من 1 من كل 10000 شخص):<br />&bull;&thinsp;تفاعلات فرط التحسس (مثل تشنج القصبات الهوائية، برفرية أو وذمة في الوجه والأطراف).<br />&bull;&thinsp;قصور في وظيفة الكلى.<br />&bull;&thinsp;تلف في الكبد.<br />&bull;&thinsp;قد يؤدي تناول سيفبودوكسيم إلى زيادة فرصة الإصابة بالالتهابات الناتجة عن أنواع أخرى من الكائنات الدقيقة<br />بشكل مؤقت، مثلا، قد يحدث مرض القلاع.<br />&bull;&thinsp;أحد أنواع فقر الدم التي قد تكون حادة وينتج عن تحلل خلايا الدم الحمراء.<br />إذا ازدادت حدة أي من الآثار الجانبية، أو إذا لاحظت حدوث أي آثار جانبية غير مذكورة في هذه النشرة، الرجاء<br />إخبار طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول الأطفال و نظرهم.<br />لا تستخدم سيفودوكس&reg; معلق للشرب بعد تاريخ انتهاء الصلاحية (EXP) المذكور على العلبة الخارجية .<br />تاريخ الانتهاء يشير الى اليوم الاخير من ذلك الشهر.<br />سيفودوكس&reg; معلق للشرب :يحفظ المسحوق الجاف بدرجة حرارة دون 30 &deg; م.<br />يجب استعمال المحلول المحضر خلال 14 يوما و يجب حفظه في الثلاجة في درجة حرارة تتراوح بين<br />(8-2 &deg;م).<br />يجب التخلص من المعلق للشرب المتبقي بعد 14 يوما بالطريقة المناسبة.<br />يجب أن لا يتم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية<br />التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; كل ملعقة 5 مل من المعلق للشرب تحتوي على 100 ملغم من المادة الفعالة سيفبودوكسيم بروكسيتيل<br />&bull; المكونات الأخرى هي هيدروكسي بروبيل سليلوز، ميكرو كريستالين سيليولوز، نشا الذرة، سكروز، حامض<br />الستريك، ثاني أكسيد السيليكون الغروي ، مستحلب السايميثيكون، ، صمغ الزنثان ، ميكرو كريستالين سيليولوز<br />+كاربوكسيميثيل سليلوز ، سكرين الصوديوم، بودرة بطعم اليمون ، بودرة بطعم الفانيلا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>الشكل الدوائي لسيفودوكس &reg;&nbsp;معلق للشرب 100ملغم / 5 مل و حجم العبوة:</p><p dir="RTL">سيفودوكس &reg;&nbsp;معلق للشرب 100ملغم / 5 مل متوفر في زجاجات 100مل ، وتأتي مع ملعقة قياس (10&nbsp;مل)&nbsp;و</p><p dir="RTL">غطاء مقاوم للأطفال .</p><p dir="RTL">تحتوي الزجاجة على مسحوق ليتم خلطه مع الماء المعقم من قبل الصيدلي، لتشكيل معلق للشرب بنكهة الليمون</p><p dir="RTL">جاهز لالستخدام.</p><p dir="RTL">(قد لا تكون جميع العبوات مسوقة في بلدك).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الدولية للدواء<br />عمان - الأردن</p><p>&nbsp;</p><p>00962 - 6 - 5158890 / 5157893 :الهاتف</p><p>00962 - 6 - 5154753 :فاكس</p><p>marketing@pic-jo.com : البريد الإلكتروني</p><p>هذه النشرة لا تحتوي على جميع المعلومات عن المستحضر. إذا كان لديك أية أسئلة أو لم تكن متأكدا من أي شيء،<br />اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             تم تنقيح هذه النشرة في 12/2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefodox® Suspension, 100mg/5ml Powder for Oral Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                When reconstituted each 5ml volume contains 100mg of the active substance (cefpodoxime proxetil)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for the preparation of an oral suspension.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefodox&reg; is a bactericidal cephalosporin antibiotic active against a wide range of Gram-negative and Gram-positive organisms. It is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity.</p><p>Indications include:<br />Upper respiratory tract infections caused by organisms sensitive to cefpodoxime, including acute otitis media, sinusitis, tonsillitis and pharyngitis.</p><p>Cefodox&reg; should be reserved for recurrent or chronic infections, or for infections where the causative organism is known or suspected to be resistant to commonly used antibiotics.</p><p>Lower respiratory tract infections caused by organisms sensitive to cefpodoxime. Including pneumonia, acute bronchitis and when bacterial super-infection complicates bronchiolitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefodox&reg; for oral suspension may be given without regard to food. The recommended dosages, durations of treatment, and applicable patient populations are as described in the following chart:</p><p><strong>Adults and Adolescents (age 12 years and older):</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:595px"><thead><tr><td style="vertical-align:bottom"><p><strong>Type of Infection</strong></p></td><td style="vertical-align:bottom"><p><strong>Total Daily Dose</strong></p></td><td style="vertical-align:bottom"><p><strong>Dose Frequency</strong></p></td><td style="vertical-align:bottom"><p><strong>Duration</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>&nbsp;Pharyngitis and/or tonsillitis</p></td><td style="vertical-align:top"><p>200 mg</p><p>(10 ml)</p></td><td style="vertical-align:top"><p>100 mg (5 ml) Q 12 hours</p></td><td style="vertical-align:top"><p>5 to 10 days</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;Acute community acquired&nbsp;pneumonia</p></td><td style="vertical-align:top"><p>400 mg</p><p>(20 ml)</p></td><td style="vertical-align:top"><p>200 mg (10 ml) Q 12 hours</p></td><td style="vertical-align:top"><p>14 days</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;Acute maxillary sinusitis</p></td><td style="vertical-align:top"><p>400 mg</p><p>(20 ml)</p></td><td style="vertical-align:top"><p>200 mg (10 ml) Q 12 hours</p></td><td style="vertical-align:top"><p>10 days</p></td></tr></tbody></table><p><strong>Infants and Pediatric Patients (age 2 months through 12 years):</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:597px"><thead><tr><td style="vertical-align:bottom"><p><strong>Type of Infection</strong></p></td><td style="vertical-align:bottom"><p><strong>Total Daily Dose</strong></p></td><td style="vertical-align:bottom"><p><strong>Dose Frequency</strong></p></td><td style="vertical-align:bottom"><p><strong>Duration</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>&nbsp;Acute otitis media</p></td><td style="vertical-align:top"><p>10 mg/kg/day</p><p>(0.5 ml/kg/day)<br />(Max 400 mg/day equ. 20ml/day)</p></td><td style="vertical-align:top"><p>5 mg/kg Q 12 h</p><p>(0.25 ml/kg Q 12 h)<br />(Max 200 mg/dose equ. 10ml/dose)</p></td><td style="vertical-align:top"><p>5 days</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;Pharyngitis and/or tonsillitis</p></td><td style="vertical-align:top"><p>10 mg/kg/day</p><p>(0.5 ml/kg/day)<br />(Max 200 mg/day equ. 10ml/day))</p></td><td style="vertical-align:top"><p>5 mg/kg/dose</p><p>Q 12 h</p><p>(0.25 ml/kg Q 12 h)<br />(Max 100 mg/dose equ. 5ml/dose)</p></td><td style="vertical-align:top"><p>5 to 10 days</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;Acute maxillary sinusitis</p></td><td style="vertical-align:top"><p>10 mg/kg/day</p><p>(0.5 ml/kg/day)<br />(Max 400 mg/day equ. 20ml/day)</p></td><td style="vertical-align:top"><p>5 mg/kg Q 12 hours</p><p>(0.25 ml/kg Q 12 h)<br />(Max 200 mg/dose equ. 10ml/dose)</p></td><td style="vertical-align:top"><p>10 days</p></td></tr></tbody></table><p><strong>Patients with Renal Dysfunction:</strong></p><p>For patients with severe renal impairment (&lt;30 mL/min creatinine clearance), the dosing intervals should be increased to Q 24 hours. In patients maintained on hemodialysis, the dose frequency should be 3 times/week after hemodialysis.<br />When only the serum creatinine level is available, the following formula (based on sex, weight, and age of the patient) may be used to estimate creatinine clearance (mL/min). For this estimate to be valid, the serum creatinine level should represent a steady state of renal function.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;Males:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Weight (kg) x (140 - age)</u>&nbsp;<br />&nbsp;&nbsp;&nbsp;(mL/min) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 72 x serum creatinine (mg/100 mL)<br /><br />&nbsp;&nbsp;&nbsp;Females: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.85 x above value<br />&nbsp;&nbsp;&nbsp;(mL/min)</p><p>Patients with Cirrhosis: Cefpodoxime pharmacokinetics in cirrhotic patients (with or without ascites) are similar to those in healthy subjects. Dose adjustment is not necessary in this population.</p><p>Instructions for Reconstitution:<br />Invert the bottle and shake powder loose. Add boiled and cooled water in two portions up to the mark indicated on the bottle; shake after each addition until a homogeneous suspension is achieved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to cefpodoxime or other cephalosporines or to any of the excipients. Previous history of immediate and/or severe hypersensitivity reactions (anaphylaxis) to penicillin or other beta-lactam antibiotic.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preliminary enquiry about allergy to penicillin is necessary before prescribing cephalosporins since cross allergy to penicillins occurs in 5-10% of cases.</p><p>Particular care will be needed in patients sensitive to penicillin: strict medical surveillance is necessary from the very first administration. Where there is doubt, medical assistance should be available at the initial administration, in order to treat any anaphylactic episode.</p><p>In patients who are allergic to other cephalosporins, the possibility of cross allergy to Cefodox&reg; should be borne in mind. Cefodox&reg; should not be given to those patients with a previous history of immediate type hypersensitivity to cephalosporins.<br />Hypersensitivity reactions (anaphylaxis) observed with beta-lactam antibiotics can be serious and occasionally fatal.<br />The onset of any manifestation of hypersensitivity indicates that treatment should be stopped.<br />Cefodox&reg; is not the preferred antibiotic for the treatment of staphylococcal pneumonia and should not be used in the treatment of atypical pneumonia caused by organisms such as Legionella, Mycoplasma and Chlamydia.<br />In cases of severe renal insufficiency it may be necessary to reduce the dosage regimen dependent on the creatinine clearance.<br />Antibiotics should always be prescribed with caution in patients with a history of gastrointestinal disease, particularly colitis. Cefodox&reg; may induce diarrhea, antibiotic associated colitis and pseudomembranous colitis. These side-effects, which may occur more frequently in patients receiving higher doses for prolonged periods, should be considered as potentially serious. The presence of C. difficile should be investigated. In all potential cases of colitis, the treatment should be stopped immediately. The diagnosis should be confirmed by sigmoidoscopy and specific antibiotic therapy (vancomycin) substituted if considered clinically necessary. The administration of products which cause faecal stasis must be avoided. Although any antibiotic may cause pseudomembranous colitis, the risk may be higher with broad-spectrum drugs, such as the cephalosporins.</p><p>As with all beta-lactam antibiotics, neutropenia, and more rarely agranulocytosis may develop, particularly during extended treatment. For cases of treatment lasting longer than 10 days, blood count should therefore be monitored, and treatment discontinued if neutropenia is found.<br />Cephalosporins may be absorbed onto the surface of red cell membranes and react with antibiotics directed against the drug. This can produce a positive Coombs&#39; test and very rarely, haemolytic anaemia. Cross-reactivity may occur with penicillin for this reaction.</p><p>The product should not be used in infants less than 15 days old as no clinical trial data in this age group yet exists.<br />Changes in renal function have been observed with antibiotics of the same class, particularly when given concurrently with potentially nephrotoxic drugs such as aminoglycosides and/or potent diuretics. In such cases, renal function should be monitored.<br />As with other antibiotics, the prolonged use of cefpodoxime proxetil may result in the overgrowth of non-susceptible organisms. With oral antibiotics the<br />normal colonic flora may be altered, allowing overgrowth by clostridia with consequent pseudomembranous colitis. Repeated evaluation of the patient is essential and if superinfection occurs during therapy, appropriate measures should be taken.<br />Patients with rare hereditary problems of galactose intolerance, fructose intolerance, the Lapp lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically significant drug interactions have been reported during the course of clinical studies.<br />Histamine H2-antagonists and antacids reduce the bioavailibility of cefpodoxime. Probenecid reduces the excretion of cephalosporins. Cephlasporins potentially enhance the anticoagulant effect of coumarins and reduce the contraceptive effect of oestrogens.<br />As with other cephalosporins, isolated cases showing development of a positive Coombs&#39; test have been reported (see Precautions).<br />Studies have shown that bioavailability is decreased by approximately 30% when Cefodox&reg; is administered with drugs which neutralize gastric pH or inhibit acid secretions. Therefore, such drugs as antacids of the mineral type and H2 blockers such as ranitidine, which cause an increase in gastric pH, should be taken 2 or 3 hours after Cefodox&reg; administration.<br />In contrast, drugs which decrease gastric pH such as pentagastrine will increase bioavailability. The clinical consequences remain to be established.<br />The bioavailability increases if the product is administered during meals.<br />A false positive reaction for glucose in the urine may occur with Benedict&#39;s or Fehling&#39;s solutions or with copper sulphate test tablets, but not with tests based on enzymatic glucose oxidase reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable since this Dosage form indicated for pediatric patients</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dizziness has been reported during treatment with cefpodoxime and may affect the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions are listed below by system organ class and frequency. Frequencies are defined as:<br />Very common (&ge;1/10)<br />Common (&ge;1/100 to &lt;1/10)<br />Uncommon (&ge;1/1,000 to &lt;1/100)<br />Rare (&ge;1/10,000 to &lt;1/1,000)<br />Very rare (&lt;1/10,000),<br />Not known (cannot be estimated from the available data)</p><table border="1" cellspacing="0" cellpadding="0" style="width:552px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Rare:</em></p></td><td style="vertical-align:top"><p>Haematological disorders such as reduction in haemoglobin, thrombocytosis, thrombocytopenia, leucopenia and eosinophilia</p></td></tr><tr><td style="vertical-align:top"><p><em>Very rare:</em></p></td><td style="vertical-align:top"><p>Haemolytic anaemia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Uncommon:</em></p></td><td style="vertical-align:top"><p>Headache, paraesthesia, dizziness</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Uncommon:</em></p></td><td style="vertical-align:top"><p>Tinnitus</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Common:</em></p></td><td style="vertical-align:top"><p>Gastric pressure, nausea, vomiting, abdominal pain, flatulence, diarrhea. Bloody diarrhoea can be seen as signs of enterocollitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>The possibility of a pseudomembranous enterocolitis should be considered if severe or persistent diarrhea occurs during or after treatment (See Section 4.4).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Metabolic and nutritional disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Common:</em></p></td><td style="vertical-align:top"><p>Loss of appetite</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders:</strong></p><p>Hypersensitivity reactions of all degrees of severity have been observed (see section 4.4).</p></td></tr><tr><td style="vertical-align:top"><p><em>Very rare:</em></p></td><td style="vertical-align:top"><p>anaphylactic reactions, bronchospasm, purpura and angioedema.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Very rare:</em></p></td><td style="vertical-align:top"><p>Slight increases in blood urea and creatinine</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Rare:</em></p></td><td style="vertical-align:top"><p>Transient moderate elevations of ASAT, ALAT and alkaline phosphatases and/or bilirubin</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>These laboratory abnormalities, which may also be explained by the infection, may rarely exceed twice the upper limit of the named range and elicit a pattern of liver injury, usually cholestatic and most often asymptomatic.</p></td></tr><tr><td style="vertical-align:top"><p><em>Very rare:</em></p></td><td style="vertical-align:top"><p>liver damage</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Uncommon:</em></p></td><td style="vertical-align:top"><p>hypersensitivity mucocutaneous reactions, rash, urticaria, pruritus</p></td></tr><tr><td style="vertical-align:top"><p><em>Very rare:</em></p></td><td style="vertical-align:top"><p>Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Infections and infestations</strong></p><p>There can be multiplication of non-sensitive micro-organisms (see section 4.4)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Uncommon:</em></p></td><td style="vertical-align:top"><p>Asthenia or malaise</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of overdosage with Cefodox&reg;, supportive and symptomatic therapy is indicated.<br />In cases of overdosage, particularly in patients with renal insufficiency, encephalopathy may occur. The encephalopathy is usually reversible once cefpodoxime plasma levels have fallen.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Other beta-lactam antibacterials, 3rd generation cephalosporins.</p><p>ATC Code: J01DD13</p><p>Mode of Action: Cefpodoxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.</p><p>PK/PD relationship For cephalosporins, the most important pharmacokinetic-pharmacodynamic index correlating with in vivo efficacy has been shown to be the percentage of the dosing interval that the unbound concentration remains above the minimum inhibitory concentration (MIC) of cefpodoxime for individual target species (i.e. %T&gt;MIC).</p><p>Mechanism(s) of resistance: Resistance to cephalosporins results from a variety of mechanisms:</p><p>1) alteration of the cell-wall permeability of gram-negative bacteria</p><p>2) alteration of the penicillin binding proteins (PBPs)</p><p>3) &beta;-lactamase production</p><p>4) bacterial efflux pumps</p><p>Breakpoints: European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints for MIC testing are presented below. EUCAST clinical MIC breakpoints for cefpodoxime (2011-01-05, v 1.3)</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p>Organism</p></td><td style="vertical-align:top"><p>Susceptible (S) (mg/l)</p></td><td style="vertical-align:top"><p>Resistant (R) (mg/l)</p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriaceae (uncomplicated UTI only)</p></td><td style="vertical-align:top"><p>&le;1</p></td><td style="vertical-align:top"><p>&gt;1</p></td></tr><tr><td style="vertical-align:top"><p>Staphylococcus spp.</p></td><td style="vertical-align:top"><p>Note<sup>1</sup></p></td><td style="vertical-align:top"><p>Note<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Streptococcus groups A, B, C and G</p></td><td style="vertical-align:top"><p>Note<sup>2</sup></p></td><td style="vertical-align:top"><p>Note<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Streptococcus pneumoniae</p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>&gt;0.5</p></td></tr><tr><td style="vertical-align:top"><p>Haemophilus influenzae</p></td><td style="vertical-align:top"><p>&le; 0.25</p><p>Note<sup>3</sup></p></td><td style="vertical-align:top"><p>&gt;0.5</p></td></tr><tr><td style="vertical-align:top"><p>Moraxella catarrhalis</p></td><td style="vertical-align:top"><p>&le; 0.25</p><p>Note<sup>3</sup></p></td><td style="vertical-align:top"><p>&gt;0.5</p></td></tr><tr><td style="vertical-align:top"><p>Neisseria gonorrhoeae</p></td><td style="vertical-align:top"><p>IE</p></td><td style="vertical-align:top"><p>IE</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoint</p></td><td style="vertical-align:top"><p>IE</p></td><td style="vertical-align:top"><p>IE</p></td></tr></tbody></table><p>1 Susceptibility of staphylococci to cephalosporins is inferred from the cefoxitin susceptibility.</p><p>2 The beta-lactam susceptibility of beta-haemolytic streptococcus groups A, B, C and G is inferred from the penicillin susceptibility.</p><p>3 Strains with MIC values above the susceptible breakpoint are very rare or not yet reported. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate must be sent to a reference laboratory.</p><p>*Insufficient evidence</p><p>Susceptibility: The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:557px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Antibacterial spectrum</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Commonly Susceptible species</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Aerobic Gram positive organisms:</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus&nbsp;</em>(Methicillin-susceptible)</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pyogenes</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Aerobic Gram negative organisms:</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Proteus mirabilis<sup>%</sup></em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Aerobic Gram positive organisms</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Aerobic Gram negative organisms</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Citrobacter freundi<sup>$</sup></em></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacter cloacae<sup>$</sup></em></p></td></tr><tr><td style="vertical-align:top"><p><em>Escherichia coli<sup>%</sup></em></p></td></tr><tr><td style="vertical-align:top"><p><em>Klebsiella pneumoniae<sup>%</sup></em></p></td></tr><tr><td style="vertical-align:top"><p><em>Serratia marcescens<sup>$</sup></em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Aerobic Gram positive organisms</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus spp.</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus (methicillin resistant)</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Aerobic Gram negative organisms</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Morganella morganii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas aeruginosa.</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Others</em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Chlamydia&nbsp;</em>spp.</p></td></tr><tr><td style="vertical-align:top"><p><em>Chlamydophila</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><em>Legionella pneumophila</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Mycoplasma</em>&nbsp;spp.</p></td></tr></tbody></table><p>$natural intermediate susceptibility</p><p>+Resistance rates &gt;50% in at least 1 region</p><p>% ESBL producing species are always resistant</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefodox&reg; is taken up in the intestine and is hydrolysed to the active metabolite cefpodoxime. When cefpodoxime proxetil is administered orally to fasting subjects as a tablet corresponding to 100mg of cefpodoxime, 51.5% is absorbed and absorption is increased by food intake. The volume of distribution is 32.3 l and peak levels of cefpodoxime occur 2 to 3 hrs after dosing. The maximum plasma concentration is 1.2mg/l and 2.5mg/l after doses of 100mg and 200mg respectively. Following administration of 100mg and 200mg twice daily over 14.5 days, the plasma pharmacokinetic parameters of cefpodoxime remain unchanged.<br />Serum protein binding of cefpodoxime, 40% principally to albumin. This binding is non saturable in type.<br />Concentrations of cefpodoxime in excess of the minimum inhibitory levels (MIC) for common pathogens can be achieved in lung parenchyma, bronchial mucosa, pleural fluid, tonsils, interstitial fluid and prostate tissue.<br />As the majority of cefpodoxime is eliminated in the urine, the concentration is high. (Concentrations in 0-4, 4-8, 8-12 hr fractions after a single dose exceed MIC90 of common urinary pathogens). Good diffusion of cefpodoxime is also seen into renal tissue, with concentrations above MIC90 of the common urinary pathogens, 3-12hrs after an administration of a single 200mg dose (1.6-3.1&mu;G/G). Concentrations of cefpodoxime in the medullary and cortical tissues is similar.<br />Studies in healthy volunteers show median concentrations of cefpodoxime in the total ejaculate 6-12hrs following administration of a single 200mg dose to be above the MIC90 of N. gonorrhoeae.<br />The main route of excretion is renal, 80% is excreted unchanged in the urine, with an elimination half life of approx 2.4 hours.<br />CHILDREN<br />In children, studies have shown the maximum plasma concentration occurs approximately 2-4 hours after dosing. A single 5mg/kg dose in 4-12 year olds produced a maximum concentration similar to that in adults given a 200mg dose.<br />In patients below 2 years receiving repeated doses of 5mg/kg 12 hourly, the average plasma concentrations, 2hrs post dose, are between 2.7mg/l (1-6 months) and 2.0mg/l (7 months-2 years).<br />In patients between 1 month and 12 years receiving repeated doses of 5mg/kg 12 hourly, the residual plasma concentrations at steady state are between 0.2-0.3mg/l (1 month-2 years) and 0.1mg/l (2-12 years).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no findings from chronic toxicity investigations suggesting that any side effects unknown to date could occur in humans.<br />Furthermore, in vivo and in vitro studies did not yield any indication of a potential to cause reproductive toxicity or mutagenicity. Studies on carcinogenicity have not been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The product contains Hydroxy propyl cellulose, Microcrystalline cellulose, Maize starch, Sucrose, Citric acid, Colloidal silicon dioxide, Simethicone oil, Microcrystalline cellulose and Carboxymethyl cellulose, Sodium saccharin, Xanthan gum, Lemon powder flavor, artificial vanilla powder flavor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported during clinical studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store dry powder below 30&deg;C.<br />The reconstituted suspension should be used within 14 days, and to be stored in the refrigerator (2-8&deg;C).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefodox&reg; Suspension 100mg/5ml Powder for Oral Suspensions are available in 100ml Amber glass bottles and come with a measuring spoon (10ml) &amp; a Child resistant cap. The bottle contains powder to be mixed with water, to form a Lemon flavoured medicine ready for use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharma Intenational Company
Amman - Jordan
Tel: 00962-6-5158890 / 5157893
Fax: 00962-6-5154753
Email: marketing@pic-jo.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>